Literature DB >> 10510315

Changes in intracellular localization of calpastatin during calpain activation.

R De Tullio1, M Passalacqua, M Averna, F Salamino, E Melloni, S Pontremoli.   

Abstract

Localization of the two main components of the Ca(2+)-dependent proteolytic system has been investigated in human neuroblastoma LAN-5 cells. Using a monoclonal antibody which recognizes the N-terminal calpastatin domain, it has been shown that this inhibitory protein is almost completely confined in two granule-like structures not surrounded by membranes. Similar calpastatin distribution has been found in other human and in murine cell types, indicating that aggregation of calpastatin is a general property and not an exclusive characteristic of neuronal-like cells. The existence of such calpastatin aggregates is confirmed by the kinetics of calpastatin-activity release during rat liver homogenization, which does not correspond to the rate of appearance of cytosolic proteins or to the disruption of membrane-surrounded organelles. Calpastatin distribution is affected by the intracellular increase in free Ca(2+), which results in calpastatin progressively becoming a soluble protein. However, calpain is distributed in the soluble cell fraction and, in activating conditions, partially accumulates on the plasma membrane. Similar behaviour has been observed in calpastatin localization in LAN-5 cells induced with retinoic acid, suggesting that the proteolytic system is activated during the differentiation process of these cells. The involvement of calpastatin in controlling calpain activity, rather than its activation process, and the utilization of changes in calpastatin localization as a marker of activation of the system is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510315      PMCID: PMC1220576     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  Identification of two calpastatin forms in rat skeletal muscle and their susceptibility to digestion by homologous calpains.

Authors:  S Pontremoli; E Melloni; P L Viotti; M Michetti; F Salamino; B L Horecker
Journal:  Arch Biochem Biophys       Date:  1991-08-01       Impact factor: 4.013

2.  Regional differences in gene expression for calcium activated neutral proteases (calpains) and their endogenous inhibitor calpastatin in mouse brain and spinal cord.

Authors:  J Li; F Grynspan; S Berman; R Nixon; S Bursztajn
Journal:  J Neurobiol       Date:  1996-06

3.  Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation.

Authors:  M Passalacqua; M Patrone; G B Picotti; M Del Rio; B Sparatore; E Melloni; S Pontremoli
Journal:  Neuroscience       Date:  1998-02       Impact factor: 3.590

Review 4.  Intracellular regulatory system involving calpain and calpastatin.

Authors:  T Murachi
Journal:  Biochem Int       Date:  1989-02

Review 5.  Calpain: new perspectives in molecular diversity and physiological-pathological involvement.

Authors:  T C Saido; H Sorimachi; K Suzuki
Journal:  FASEB J       Date:  1994-08       Impact factor: 5.191

6.  Modulation of the calpain autoproteolysis by calpastatin and phospholipids.

Authors:  E Melloni; M Michetti; F Salamino; R Minafra; S Pontremoli
Journal:  Biochem Biophys Res Commun       Date:  1996-12-04       Impact factor: 3.575

7.  Identification and characterization of inhibitory sequences in four repeating domains of the endogenous inhibitor for calcium-dependent protease.

Authors:  H Kawasaki; Y Emori; S Imajoh-Ohmi; Y Minami; K Suzuki
Journal:  J Biochem       Date:  1989-08       Impact factor: 3.387

8.  A comparison of the intracellular distribution of mu-calpain, m-calpain, and calpastatin in proliferating human A431 cells.

Authors:  R D Lane; D M Allan; R L Mellgren
Journal:  Exp Cell Res       Date:  1992-11       Impact factor: 3.905

Review 9.  Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease.

Authors:  R A Nixon; K I Saito; F Grynspan; W R Griffin; S Katayama; T Honda; P S Mohan; T B Shea; M Beermann
Journal:  Ann N Y Acad Sci       Date:  1994-12-15       Impact factor: 5.691

10.  Beta-adrenergic agonists that down-regulate receptor mRNA up-regulate a M(r) 35,000 protein(s) that selectively binds to beta-adrenergic receptor mRNAs.

Authors:  J D Port; L Y Huang; C C Malbon
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

View more
  18 in total

1.  Changes in intracellular calpastatin localization are mediated by reversible phosphorylation.

Authors:  M Averna; R de Tullio; M Passalacqua; F Salamino; S Pontremoli; E Melloni
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

2.  Ca2+ activation of diffusible and bound pools of mu-calpain in rat skeletal muscle.

Authors:  Robyn M Murphy; Esther Verburg; Graham D Lamb
Journal:  J Physiol       Date:  2006-07-20       Impact factor: 5.182

Review 3.  Calpain and synaptic function.

Authors:  Hai-Yan Wu; David R Lynch
Journal:  Mol Neurobiol       Date:  2006-06       Impact factor: 5.590

4.  v-Src-induced modulation of the calpain-calpastatin proteolytic system regulates transformation.

Authors:  N O Carragher; M A Westhoff; D Riley; D A Potter; P Dutt; J S Elce; P A Greer; M C Frame
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 5.  The calpain system and cancer.

Authors:  Sarah J Storr; Neil O Carragher; Margaret C Frame; Tim Parr; Stewart G Martin
Journal:  Nat Rev Cancer       Date:  2011-05       Impact factor: 60.716

Review 6.  Calpain as a therapeutic target in traumatic brain injury.

Authors:  Kathryn E Saatman; Jennifer Creed; Ramesh Raghupathi
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

7.  Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis.

Authors:  Roberto Stifanese; Monica Averna; Roberta De Tullio; Marco Pedrazzi; Francesco Beccaria; Franca Salamino; Marco Milanese; Giambattista Bonanno; Sandro Pontremoli; Edon Melloni
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

8.  Functional role of HSP90 complexes with endothelial nitric-oxide synthase (eNOS) and calpain on nitric oxide generation in endothelial cells.

Authors:  Monica Averna; Roberto Stifanese; Roberta De Tullio; Mario Passalacqua; Franca Salamino; Sandro Pontremoli; Edon Melloni
Journal:  J Biol Chem       Date:  2008-08-05       Impact factor: 5.157

9.  Cellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegeneration.

Authors:  Alison J B Markowitz; Michael G White; Dennis L Kolson; Kelly L Jordan-Sciutto
Journal:  Cellscience       Date:  2007-07-27

10.  In situ measurements of calpain activity in isolated muscle fibres from normal and dystrophin-lacking mdx mice.

Authors:  P Gailly; F De Backer; M Van Schoor; J M Gillis
Journal:  J Physiol       Date:  2007-05-17       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.